• Accueil >
  • Publications >
  • Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

1 sept. 2018European Journal of Cancer

DOI : 10.1016/j.ejca.2018.05.002

Auteurs

Lucas Moreno, Michela Casanova, Julia C. Chisholm, Pablo Berlanga, Pascal B. Chastagner, Sylvain Baruchel, Loredana Amoroso, Soledad Gallego Melcón, Nicolas U. Gerber, Gianni Bisogno, Franca Fagioli, Birgit Geoerger, Julia L. Glade Bender, Isabelle Aerts, Christophe Bergeron, Pooja Hingorani, Ileana Elias, Mathew Simcock, Stefano Ferrara, Yvan Le Bruchec, Ruta Slepetis, Nianhang Chen, Gilles Vassal